IL13RA2 and glioblastoma: Based on the analysis of antigen variability across GBM patient cell lines, Bielamowicz and colleagues have since developed a tri-cistronic CAR transgene encompassing IL-13Rα2, EphA2, and HER2, which they called universal CAR (UCAR) (142).